Dr. Jack Cush, Dr. Aurelie Najam ( @AurelieRheumo) , Dr. Bella Mehta ( @bella_mehta) Dr. Yuz Yusof ( @Yuz6Yusof), Dr. Pedro Castillo ( @_Castillo_Pedro) and Dr. Richard Conway ( @RichardPAConway) discuss highlights from the first full day of the #ACR21. https://t.co/eLrAzYvcMG https://t.co/c5gGfFK1KO

• https://bit.ly/3D1f9Z6

RA Risk in Cardiovascular Disease: Dr. Eric Dein ( @ericdeinmd ) discusses abstracts #0269 and #0271 presented at the #ACR21 annual meeting. https://t.co/qSdfuqKbMI https://t.co/Lw1rGGF2Zt

• https://bit.ly/2YtgGZ9

Does RA Begin in the Gut? Dr. Jonathan Kay reviews abstract #0461 presented at the #ACR21 annual meeting. https://t.co/Q2WrJ8XYUZ https://t.co/jLaczx9ya4

• https://bit.ly/3wqd5HT

RheumNow’s expanded coverage of the #ACR21 annual meeting is sponsored in part by @Novartis. All content chosen by RheumNow & its Faculty.

Lupus Updates with Dr. Michelle Petri https://t.co/4YZt4Pko4z https://t.co/MaXV5EXEVv

• https://bit.ly/3o8YMna

Infection or Disease Flare: What Tools Can Help Differentiate? Dr. Olga Petryna ( @DrPetryna) shares studies presented at #ACR21. https://t.co/EOwgjdCzUO https://t.co/bbwLfNq2cO

• https://bit.ly/3bTxtrk

Evolution of Rheumatoid Arthritis: Arthur Kavanaugh Dr. Arthur Kavanaugh reviews several RA-related studies presented at the #ACR21 annual meeting. https://t.co/LdeMH1k362

Which achievable Target could reduce mortality by just over 50% in #lupus 🦋? Do watch my video on Treat to Target in SLE: Dr. Yuzaiful Yusof https://t.co/H8kgFW9H06 via @YouTube @RheumNow

• Treat to Target in SLE: Dr. Yuzaiful Yusof - YouTube

RheumNow’s expanded coverage of the #ACR21 annual meeting is sponsored in part by @bmsnews, @JanssenUS, @Novartis. All content chosen by RheumNow & its Faculty.

The PROOF Study in AxSpA: Dr. Sheila Reyes ( @RHEUMarampa ) discusses abstract #0363 presented at the #ACR21 annual meeting. https://t.co/mkKakbYHKb https://t.co/dUhlolIvBR

• https://bit.ly/3o3uxhu

Axial spondyloarthritis with psoriasis or psoriatic spondylitis Dr. Antoni Chan ( @synovialjoints ) shares learnings from #ACR21. https://t.co/ZH9IC2iViF https://t.co/nmq5PGzWJV

• https://bit.ly/3GWYyIx

Vexed about VEXAS: Dr. Janet Pope ( @Janetbirdope) discusses abstracts #1104, #1426 and #1457 presented at the #ACR21 annual meeting. https://t.co/SBjJsixHXy https://t.co/PVnUB60EXQ

• https://bit.ly/306A0vL

So great to get some insights about this from @SeoyoungCKim for @RheumNow: https://t.co/Snj8pejT7U While we're all a bit disappointed about the possibility of safety issues for one of our brightest, most important Rx, better with info that helps us understand and mitigate #ACR21

• Tofacitinib and Malignancy Risk: Dr. Seoyoung Kim | RheumNow

Closing a Chapter: My Interview w/ @DrDavidKarp, 84th ACR President 2020-2021 👉🏼what he considers important 👉🏼advice for @KenSaag (85th ACR president) 👉🏼what he’s going to do next (and no, there is no 2nd term) @ACRheum #ACR21 @RheumNow https://t.co/bIIBzWMbnI

• Closing a Chapter: Interview with Dr. David Karp, 84th ACR President 2020-2021 …